Checkpoint inhibitor response prediction milestone using patient-derived ex vivo spheroids

Greenville, SC – March 11, 2021 – KIYATEC, Inc researchers demonstrated that their immune-modified ex vivo platform can measure treatment response through direct interaction between a patient’s cancer and infiltrating immune cells, and immuno-oncology agents. This work, published in the March 2021 issue of Cancer Immunology, Immunotherapy, validates the use of this platform in a…

Updated guidance confirms crucial role of nurses for patients with acute ischemic stroke

DALLAS, March 11, 2021 — As integral members of stroke treatment teams, nurses coordinate patient assessment and collaborate care among multiple health care professionals to facilitate the best possible outcomes for patients with acute ischemic stroke. Nurses also advocate for patients and their caregivers to ensure they receive appropriate information and education to successfully navigate…

New report reveals how the U.S. can renew its leadership in global health R&D

The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global health research and development (R&D) in the wake of a pandemic that has revealed both the sector’s chronic neglect and amazing potential, according to a detailed agency-by-agency action plan released today by the nonprofit Global Health Technologies Coalition (GHTC). “The same core…